Abstract
Background
Treatments for patients with gastric outlet obstruction (GOO) due to unresectable pancreatic cancers (URPC) include gastrojejunostomy (GJJ) and endoscopic duodenal stent placement (EDSP). This study compared the efficacy and safety of GJJ and EDSP in patients with GOO due to URPC.
Methods
This study retrospectively evaluated consecutive patients with GOO due to URPC who underwent GJJ or EDSP between April 2016 and March 2020. The efficacy and safety of GJJ and EDSP were compared with propensity score analysis. Subgroup analyses of overall survival (OS) were compared after propensity matching.
Results
Data were obtained from 54 patients who underwent GJJ and from 73 who underwent EDSP at five tertiary care hospitals. After propensity matching, OS was significantly longer in patients who underwent GJJ than EDSP (110 vs. 63 days, respectively; p = 0.019). Evaluation of long-term adverse events showed that the frequency of cholangitis and obstructive jaundice was significantly lower in the matched GJJ than in the matched EDSP group (p = 0.012). Subgroup analyses showed that OS in patients with good performance status (PS; p = 0.041), biliary obstruction (p = 0.007), and duodenal obstruction near the papilla (p = 0.027), and those receiving chemotherapy (p = 0.010), was significantly longer in the matched GJJ group than in matched EDSP group.
Conclusion
GJJ provides longer OS than EDSP for patients with GOO caused by URPC, especially for patients with good PS, biliary obstruction, and duodenal obstruction near the papilla, and those receiving chemotherapy.
Similar content being viewed by others
References
Lillemoe KD, Cameron JL, Hardacre JM, Sohn TA, Sauter PK, Coleman J et al (1999) Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 230(3):322–328 (discussion 8-30)
Khashab M, Alawad AS, Shin EJ, Kim K, Bourdel N, Singh VK et al (2013) Enteral stenting versus gastrojejunostomy for palliation of malignant gastric outlet obstruction. Surg Endosc 27(6):2068–2075
Adler DG, Baron TH (2002) Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. Am J Gastroenterol 97(1):72–78
Kaw M, Singh S, Gagneja H, Azad P (2003) Role of self-expandable metal stents in the palliation of malignant duodenal obstruction. Surg Endosc 17(4):646–650
Fiori E, Lamazza A, Volpino P, Burza A, Paparelli C, Cavallaro G et al (2004) Palliative management of malignant antro-pyloric strictures Gastroenterostomy vs. endoscopic stenting. A randomized prospective trial. Anticancer Res 24(1):269–271
Mehta S, Hindmarsh A, Cheong E, Cockburn J, Saada J, Tighe R et al (2006) Prospective randomized trial of laparoscopic gastrojejunostomy versus duodenal stenting for malignant gastric outflow obstruction. Surg Endosc 20(2):239–242
Jeurnink SM, Steyerberg EW, van Hooft JE, van Eijck CH, Schwartz MP, Vleggaar FP et al (2010) Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc 71(3):490–499
Chandrasegaram MD, Eslick GD, Mansfield CO, Liem H, Richardson M, Ahmed S et al (2012) Endoscopic stenting versus operative gastrojejunostomy for malignant gastric outlet obstruction. Surg Endosc 26(2):323–329
Roy A, Kim M, Christein J, Varadarajulu S (2012) Stenting versus gastrojejunostomy for management of malignant gastric outlet obstruction: comparison of clinical outcomes and costs. Surg Endosc 26(11):3114–3119
Tsauo J, Yoo MW, Song HY, Hwang DW, Park JH, Ryu MH et al (2016) Partially-covered stent placement versus surgical gastrojejunostomy for the palliation of malignant gastroduodenal obstruction secondary to pancreatic cancer. Abdominal Radiology (New York) 41(11):2233–2240
Yoshida Y, Fukutomi A, Tanaka M, Sugiura T, Kawata N, Kawai S et al (2017) Gastrojejunostomy versus duodenal stent placement for gastric outlet obstruction in patients with unresectable pancreatic cancer. Pancreatology 17(6):983–989
Katayama H, Kurokawa Y, Nakamura K, Ito H, Kanemitsu Y, Masuda N et al (2016) Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today 46(6):668–685
Gum PA, Thamilarasan M, Watanabe J, Blackstone EH, Lauer MS (2001) Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease: a propensity analysis. JAMA 286(10):1187–1194
Luo Z, Gardiner JC, Bradley CJ (2010) Applying propensity score methods in medical research: pitfalls and prospects. Med Care Res Rev: MCRR 67(5):528–554
Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 48(3):452–458
Azemoto N, Ueno M, Yanagimoto H, Mizuno N, Kawamoto Y, Maruki Y et al (2022) Endoscopic duodenal stent placement versus gastrojejunostomy for unresectable pancreatic cancer patients with duodenal stenosis before introduction of initial chemotherapy (GASPACHO study): a multicenter retrospective study. Jpn J Clin Oncol 52(2):134–142
Jang SH, Lee H, Min BH, Kim SM, Kim HS, Carriere KC et al (2017) Palliative gastrojejunostomy versus endoscopic stent placement for gastric outlet obstruction in patients with unresectable gastric cancer: a propensity score-matched analysis. Surg Endosc 31(10):4217–4223
Haga Y, Hiki N, Kinoshita T, Ojima T, Nabeya Y, Kuwabara S et al (2020) Treatment option of endoscopic stent insertion or gastrojejunostomy for gastric outlet obstruction due to gastric cancer: a propensity score-matched analysis. Gastric Cancer 23(4):667–676
Migita K, Takayama T, Matsumoto S, Wakatsuki K, Tanaka T, Ito M et al (2016) Impact of being underweight on the long-term outcomes of patients with gastric cancer. Gastric Cancer 19(3):735–743
Lien YC, Hsieh CC, Wu YC, Hsu HS, Hsu WH, Wang LS et al (2004) Preoperative serum albumin level is a prognostic indicator for adenocarcinoma of the gastric cardia. J Gastrointest Surg 8(8):1041–1048
Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y et al (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364(19):1817–1825
Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M et al (2013) Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 369(18):1691–1703
Yamao K, Kitano M, Chiba Y, Ogura T, Eguchi T, Moriyama I et al (2021) Endoscopic placement of covered versus uncovered self-expandable metal stents for palliation of malignant gastric outlet obstruction. Gut 70(7):1244–1252
Nakai Y, Hamada T, Isayama H, Itoi T, Koike K (2017) Endoscopic management of combined malignant biliary and gastric outlet obstruction. Digestive Endosc 29(1):16–25
Abbas A, Dolan RD, Bazarbashi AN, Thompson CC (2022) Endoscopic ultrasound-guided gastroenterostomy versus surgical gastrojejunostomy for the palliation of gastric outlet obstruction in patients with peritoneal carcinomatosis. Endoscopy. https://doi.org/10.1055/a-1708-0037
Boghossian MB, Funari MP, De Moura DTH, McCarty TR, Sagae VMT, Chen YI et al (2021) EUS-guided gastroenterostomy versus duodenal stent placement and surgical gastrojejunostomy for the palliation of malignant gastric outlet obstruction: a systematic review and meta-analysis. Langenbecks Arch Surg 406(6):1803–1817
Acknowledgements
The authors thank all the members of the Second Department of Internal Medicine, Second Department of Surgery and Clinical Study Support Center at Wakayama Medical University, Department of Gastroenterology and Hepatology and Department of Surgery at Kindai University Faculty of Medicine, Department of Surgery and Department of Gastroenterology at Nara Medical University, Second Department of Internal Medicine and Department of general and gastroenterological surgery at Osaka Medical and Pharmaceutical University and Department of Surgery and Department of Medicine, Shiga University of Medical Science
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
Masayuki Kitano has received honoraria from Olympus Corporation for delivering lectures at conferences and grants from Boston Scientific. Takashi Tamura, Takenaka Mamoru, Taichi Terai, Takeshi Ogura, Masaji Tani, Toshio Shimokawa, Yuji Kitahata, Ippei Matsumoto, Akira Mitoro, Mitsuhiro Asakuma, Osamu Inatomi, Shunsuke Omoto, Masayuki Sho, Saori Ueno and Hiromitsu Maehira have no conflict of interest or financial ties to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tamura, T., Mamoru, T., Terai, T. et al. Gastrojejunostomy versus endoscopic duodenal stent placement for gastric outlet obstruction in patients with unresectable pancreatic cancer: a propensity score-matched analysis. Surg Endosc 37, 1890–1900 (2023). https://doi.org/10.1007/s00464-022-09685-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-022-09685-x